Genomics-Led Cancer Care Begins In Navi Mumbai.

Mumbai, Maharashtra, 18th of February, 2026 : Cancer treatment in Navi Mumbai has entered a transformative phase with Apollo Hospitals Navi Mumbai launching its Precision Oncology Clinic. The initiative introduces genomics-based personalized cancer care, tailoring treatment plans according to a patient’s genomic profile, biomarker subtype, age, lifestyle factors, comorbidities, and individual treatment goals.

Dr. Jyoti Bajpai, Lead Consultant – Medical & Precision Oncology, said, “Genomics not only identifies the type of cancer a patient has but also reveals its specific subtype. For instance, breast cancer may be Luminal A, Luminal B, Triple-Negative, or HER2-positive, and each behaves differently and responds uniquely to therapy. Precision oncology enables us to select the right drug, at the right dose, for the right patient.”

Mr. Arunesh Punetha, Regional CEO – Western Region, added, “We are moving beyond the ‘one-size-fits-all’ approach. Every patient will now receive care aligned with their biology, profession, preferences, and life circumstances.”

With advanced genomic sequencing, targeted therapies, and multidisciplinary tumor board reviews, the clinic aims to deliver safer, more predictable, and outcome-focused cancer treatment.